Candriam SCA’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-91,275
| Closed | -$2.78M | – | 721 |
|
|
2023
Q4 | $2.78M | Buy |
91,275
+40,000
| +78% | +$1.22M | 0.02% | 433 |
|
|
2023
Q3 | $1.62M | Sell |
51,275
-40,000
| -44% | -$1.26M | 0.01% | 479 |
|
|
2023
Q2 | $3.72M | Hold |
91,275
| – | – | 0.03% | 383 |
|
|
2023
Q1 | $3.13M | Hold |
91,275
| – | – | 0.02% | 470 |
|
|
2022
Q4 | $3.18M | Sell |
91,275
-50,000
| -35% | -$1.74M | 0.02% | 485 |
|
|
2022
Q3 | $7.91M | Hold |
141,275
| – | – | 0.06% | 315 |
|
|
2022
Q2 | $7.31M | Buy |
141,275
+40,148
| +40% | +$2.08M | 0.06% | 273 |
|
|
2022
Q1 | $7.35M | Hold |
101,127
| – | – | 0.05% | 296 |
|
|
2021
Q4 | $12M | Hold |
101,127
| – | – | 0.08% | 238 |
|
|
2021
Q3 | $13.6M | Hold |
101,127
| – | – | 0.09% | 229 |
|
|
2021
Q2 | $16.4M | Sell |
101,127
-81,790
| -45% | -$13.2M | 0.11% | 214 |
|
|
2021
Q1 | $9.56M | Hold |
182,917
| – | – | 0.08% | 255 |
|
|
2020
Q4 | $9.95M | Buy |
+182,917
| New | +$9.95M | 0.08% | 261 |
|
|
2019
Q4 | – | Sell |
-120,000
| Closed | -$1.6M | – | 803 |
|
|
2019
Q3 | $1.6M | Hold |
120,000
| – | – | 0.02% | 534 |
|
|
2019
Q2 | $1.96M | Hold |
120,000
| – | – | 0.02% | 521 |
|
|
2019
Q1 | $2.05M | Hold |
120,000
| – | – | 0.03% | 493 |
|
|
2018
Q4 | $1.64M | Hold |
120,000
| – | – | 0.03% | 500 |
|
|
2018
Q3 | $3.43M | Buy |
120,000
+20,300
| +20% | +$581K | 0.05% | 392 |
|
|
2018
Q2 | $2.73M | Buy |
99,700
+19,700
| +25% | +$539K | 0.04% | 416 |
|
|
2018
Q1 | $1.69M | Buy |
80,000
+15,000
| +23% | +$316K | 0.03% | 509 |
|
|
2017
Q4 | $1.25M | Buy |
+65,000
| New | +$1.25M | 0.02% | 547 |
|